0


含valosin蛋白(VCP)在肌萎缩侧索硬化症毒性错误折叠蛋白聚集体清除中的作用

The role of valosin containing protein (VCP) in the clearance of toxic misfolded protein aggregates in amyotrophic lateral sclerosis
课程网址: http://videolectures.net/encals2017_ferrari_lateral_sclerosis/  
主讲教师: Veronica Ferrari
开课单位: 米兰大学
开课时间: 2017-07-21
课程语种: 英语
中文简介:
肌萎缩侧索硬化症(ALS)分为散发型(SAL)和家族型(FAL),前者在90%的病例中出现,后者在其余10%的病例中出现。这两种形式都以细胞内聚集物的存在为特征。除了与超氧化物歧化酶1(SOD1)相关的外,sALS和fALS的特征是含有TAR-DNA结合蛋白43(TDP-43)阳性的内含物。这些包涵体隔离了重要的细胞成分,并可能损害蛋白质控制质量(PQC)系统。PQC系统也可以通过表达系统相关蛋白的基因突变而改变。在fALS中发现的突变基因之一是含Valosin蛋白(VCP)。VCP是AAA+ATP酶家族的成员,是参与PQC系统的伴侣样蛋白。VCP作为均六聚体工作,包含两个ATP酶单元和一个N端单元。N端单元与大量适配器相互作用,允许VCP参与PQC系统的各种通路。VCP的作用主要是将错误折叠的蛋白质路由到泛素-蛋白酶体系统(UPS),但最近发现VCP也参与自噬途径。最近的研究表明,在VCP-ALS患者中,以及在发现VCP突变的其他疾病中,脑组织的特征是含有TDP-43阳性的内含物。实验工作还将VCP突变体与自噬途径的损伤相关,表明VCP参与清除细胞内包涵体及其在疾病中的损伤。在这里,我们报告在ALS体外模型中VCP的过度表达主要通过UPS增强突变SOD1聚集体的清除。此外,VCP似乎在去除TDP-43骨料方面也有作用。事实上,VCP的化学抑制增加了TDP-43的聚集。这些数据开始定义VCP在清除错误折叠蛋白聚集体中的重要性,错误折叠蛋白聚集体是ALS和其他神经退行性疾病中细胞毒性的原因。这些发现可能使VCP成为ALS的一个新的潜在靶点。
课程简介: Amyotrophic lateral sclerosis (ALS) is classified in sporadic forms (sALS) present in 90 % of the cases and familial forms (fALS) present in the remaining 10% of the cases. Both forms are characterized by the presence of intracellular aggregates. sALS and fALS, except those related to Superoxide Dismutase 1 (SOD1), are characterized by inclusions positive for TAR-DNA binding protein 43 (TDP-43). These inclusions sequester essential cellular components and could impair the Protein Control Quality (PQC) system. The PQC system can also be altered by the mutation of genes that express proteins involved in the system. One of the genes found mutated in fALS is Valosin Containing Protein (VCP). VCP is a member of the AAA+ ATPase family that are chaperon-like proteins involved in the PQC system. VCP works as a homohexamer and contains two ATPase units and an N-terminal unit. The N-terminal unit interacts with a large number of adaptors that permits VCP to be involved in various pathways of the PQC system. VCP role is to route misfolded proteins mainly to the Ubiquitin Proteasome System (UPS) but recently VCP was found involved also in the autophagic pathway. Recent studies show that in VCP-ALS patients, as well as in other diseases where VCP is found mutated, the brain tissue is characterized by inclusions positive for TDP-43. Experimental work also correlated VCP-mutants to the impairment of the autophagic pathway, suggesting an involvement of VCP in the clearance of intracellular inclusion and its impairment in disease. Here we report that the overexpression of VCP in an ALS in vitro model enhances the clearance of mutated SOD1-aggregates mainly through the UPS. Moreover, VCP seems to have a role also in the removal of TDP-43 aggregates. In fact the chemical inhibition of VCP increases the aggregation of TDP- 43. These data start to define VCP importance in the clearance of misfolded protein aggregates, which are the cause of cell-toxicity in ALS and other neurodegenerative diseases. These findings could make VCP a new potential target for ALS.
关 键 词: 肌萎缩侧索硬化症; 散发型; 家族型
课程来源: 视频讲座网
数据采集: 2021-12-22:zkj
最后编审: 2021-12-22:zkj
阅读次数: 148